Bharat Immunological Biological Corporation Ltd vs Lactose India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 17.3 as of 06 May 15:30 . The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Lactose (India) Ltd changed from 30.7 on March 2022 to 21.6 on March 2025 . This represents a CAGR of -8.41% over 4 years The Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 196.47 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Lactose (India) Ltd changed from ₹ 30.54 crore on March 2021 to ₹ 111.66 crore on March 2025 . This represents a CAGR of 29.60% over 5 years The revenue of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Lactose (India) Ltd for the Dec '25 is ₹ 37.4 crore as compare to the Sep '25 revenue of ₹ 41.55 crore. This represent the decline of -9.99% The ebitda of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Lactose (India) Ltd for the Dec '25 is ₹ 3.7 crore as compare to the Sep '25 ebitda of ₹ 5.63 crore. This represent the decline of -34.28% The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Lactose (India) Ltd changed from ₹ 2.27 crore to ₹ 0.53 crore over 7 quarters. This represents a CAGR of -56.45% The Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Lactose (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bharat Immunological & Biological Corporation Ltd

The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
BIBCOL was incorporated in 1989.
The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
BIBCL installed a plant of 100 mln units.
Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

About Lactose (India) Ltd

Lactose (India) Limited was incorporated on March 1991 as a Public Limited Company in Vadodara district of Gujarat.
Company engages in the manufacturing and trading of pharmaceutical products.
It edible and pharmaceutical grade lactose, as an ingredient used in pharmaceutical products, as well as in dairy, food, confectionery, and beverage industries.
It also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee.
Further, it engage in the contract manufacture of pharmaceutical products. The company is having their manufacturing facilities located at Vadodara in Gujarat.

FAQs for the comparison of Bharat Immunological & Biological Corporation Ltd and Lactose (India) Ltd

Which company has a larger market capitalization, Bharat Immunological & Biological Corporation Ltd or Lactose (India) Ltd?

Market cap of Bharat Immunological & Biological Corporation Ltd is 74 Cr while Market cap of Lactose (India) Ltd is 147 Cr

What are the key factors driving the stock performance of Bharat Immunological & Biological Corporation Ltd and Lactose (India) Ltd?

The stock performance of Bharat Immunological & Biological Corporation Ltd and Lactose (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Immunological & Biological Corporation Ltd and Lactose (India) Ltd?

As of May 6, 2026, the Bharat Immunological & Biological Corporation Ltd stock price is INR ₹17.3. On the other hand, Lactose (India) Ltd stock price is INR ₹117.0.

How do dividend payouts of Bharat Immunological & Biological Corporation Ltd and Lactose (India) Ltd compare?

To compare the dividend payouts of Bharat Immunological & Biological Corporation Ltd and Lactose (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.